ORPHA:1546
Cryptococcosis
Publications
27,910
Trials
7
Interventional, condition-specific
Researchers
1,236
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A cosmopolitan fungal infection due to Cryptococcus neoformans.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0005724
- MeSH:D003453
- UMLS:C0010414
- NCIT:C2967
Additional Mondo synonyms (4)
Cryptococcus neoformans caused disease or disorder · Cryptococcus neoformans disease or disorder · Cryptococcus neoformans infectious disease · torulosis
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
27,910 matched papers (12,096 in last 10 years) Source
- Phenotype characterisedPresent
42 HPO annotations (e.g. Fever; Abnormality of the eye; Mental deterioration) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationPartial
2 EMA designations (none yet with FDA orphan-indication approval) — e.g. 1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride Source
- Interventional trialPresent
7 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
42
Associated phenotypes · MONDO:0005724
- Fever
- Abnormality of the eye
- Mental deterioration
- Cirrhosis
- Vomiting
Showing 5 of 42 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
2
Designations · no FDA orphan-indication approval yet
- EMA 1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochlorideTreatment of cryptococcosis · 24/04/2015 · PositiveEMA designation
- EMA amphotericin BTreatment of cryptococcosis · 10/08/2022 · WithdrawnEMA designation
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
4
Drugs / clinical candidates · MONDO_0005724
- AMCIPATRICIN DIASCORBATE·phase 3
- AMPHOTERICIN B·approval
- ISAVUCONAZONIUM SULFATE·approval
- OTESECONAZOLE·phase 2 3
CTD chemicals (MyDisease.info)
7 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Amphotericin B · therapeutic
- amphotericin B, deoxycholate drug combination · therapeutic
- Fluconazole · therapeutic
- Flucytosine · therapeutic
- Itraconazole · therapeutic
- Ketoconazole · therapeutic
- tebuconazole · therapeutic
Literature
Is anyone studying this?
27,910
27,910 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
27,910 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
12,096 in the last 10 years · low confidence
Phrase hits: 27,910 · MeSH hits: 0
Who's working on it?
1,236
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Wang H6 papers · 2026
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Papers in Europe PMC - 02Boulware DR5 papers · 2026
Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Papers in Europe PMC - 03Casadevall A5 papers · 2026
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health.
Papers in Europe PMC - 04Chen X4 papers · 2026
State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, Northwest A&F University, Yangling, Shaanxi, PR China.
Papers in Europe PMC - 05Wang Q4 papers · 2026
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Papers in Europe PMC - 06Wang Y4 papers · 2026
State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, Northwest A&F University, Yangling, Shaanxi, PR China.
Papers in Europe PMC - 07Xu Y4 papers · 2026
State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, Northwest A&F University, Yangling, Shaanxi, PR China.
Papers in Europe PMC - 08Chen M3 papers · 2026
Department of Ultrasound, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Papers in Europe PMC - 09Chen Y3 papers · 2026
Department of Dermatology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China.
Papers in Europe PMC - 10Gu L3 papers · 2026
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
7
interventional trials for this specific condition
7 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026
7 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 90.9th percentile).
low confidence · 90.9th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
7 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
8 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT00001352·RECRUITING·Fungal Infection Susceptibility
Not reviewed·Conditions: Cryptococcal Infection · Cryptococcal Pneumonia · Pulmonary Cryptococcosis · Cryptococcal Meningitis·Matched via name phrase
- NCT02454569·RECRUITING·Vicente Ferrer HIV Cohort Study
Not reviewed·Conditions: HIV · Tuberculosis · Cryptococcosis · Opportunistic Infections·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 5 · after dedupe 4 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 4 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (4)
- ctis·2024-514792-17-00·Authorised, ongoing·ODORAT : Optimal dose of anti-lymphocyte globulin in kidney transplant recipients with low immunological risk
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN56244307·No longer recruiting·A study to assess the safety and efficacy of a gel treatment in subjects with acne vulgaris
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN49040930·No longer recruiting·A long-term study to assess the safety and efficacy of a gel treatment in subjects with Acne Vulgaris
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11882960·No longer recruiting·Improvement in cryptococcosis diagnosis among HIV-infected patients in Mozambique
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Cryptococcosis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Cryptococcosis" OR "Cryptococcus neoformans infectious disease" OR "torulosis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Cryptococcosis" OR "Cryptococcus neoformans infectious disease" OR "torulosis"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 7 interventional · 8 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: Cryptococcus neoformans caused disease or disorder; Cryptococcus neoformans disease or disorder
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (27910) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T17:41:19.890Z
